Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study

Contributed by: PR Newswire

Tags

Medinol-FIH-study

More Like This

PR Newswire associated0

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

PR Newswire associated0

Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

PR Newswire associated0

AuriGen Medical Pioneers Next-Generation Atrial Fibrillation Technology with First-in-Human Success

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

PR Newswire associated0

Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches